DOI: 10.1055/s-00000088

TumorDiagnostik & Therapie

References

Bear HD, Tang G, Rastogi P. et al.
Neoadjuvant plus adjuvant bevacizumab in early breast cancer (NSABP B‑40 [NRG Oncology]): secondary outcomes of a phase 3, randomised controlled trial.

Lancet Oncol 2015;
16: 1037-1048

Download Bibliographical Data

Access:
Access:
Access: